These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16377834)

  • 1. Ventricular cerebrospinal fluid hypocretin-1 inversely correlates with glucose levels in cerebrospinal fluid and serum from patients with neurological injuries.
    Doherty MJ; Watson NF; Hallam DK; Chandler WL; Longstreth WT
    Neurocrit Care; 2005; 3(3):230-3. PubMed ID: 16377834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
    Heier MS; Jansson TS; Gautvik KM
    J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
    Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
    Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
    Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
    Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.
    Nishino S; Ripley B; Overeem S; Nevsimalova S; Lammers GJ; Vankova J; Okun M; Rogers W; Brooks S; Mignot E
    Ann Neurol; 2001 Sep; 50(3):381-8. PubMed ID: 11558795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls.
    Slats D; Claassen JA; Lammers GJ; Melis RJ; Verbeek MM; Overeem S
    Curr Alzheimer Res; 2012 Dec; 9(10):1119-25. PubMed ID: 22742854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.
    Aran A; Shors I; Lin L; Mignot E; Schimmel MS
    Sleep; 2012 Feb; 35(2):187-91. PubMed ID: 22294808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
    Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats.
    Yoshida Y; Fujiki N; Maki RA; Schwarz D; Nishino S
    Neurosci Lett; 2003 Aug; 346(3):182-6. PubMed ID: 12853114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased CSF hypocretin-1 (orexin-A) after acute haemorrhagic brain injury.
    Rejdak K; Petzold A; Lin L; Smith M; Kitchen N; Thompson EJ
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):597-8. PubMed ID: 15774458
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
    Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
    Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
    Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients.
    Papuć E; Stelmasiak Z; Grieb P; Paweł G; Rejdak K
    Neurosci Lett; 2010 Apr; 474(1):9-12. PubMed ID: 20193740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy.
    Heier MS; Skinningsrud A; Paus E; Gautvik KM
    Sleep Med; 2014 Jun; 15(6):614-8. PubMed ID: 24784789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF hypocretin measures in patients with obstructive sleep apnea.
    Kanbayashi T; Inoue Y; Kawanishi K; Takasaki H; Aizawa R; Takahashi K; Ogawa Y; Abe M; Hishikawa Y; Shimizu T
    J Sleep Res; 2003 Dec; 12(4):339-41. PubMed ID: 14633246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.
    John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM
    J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.